First Heartland Consultants’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,419
Closed -$651K 264
2018
Q3
$651K Sell
3,419
-970
-22% -$178K 0.2% 110
2018
Q2
$732K Sell
4,389
-835
-16% -$134K 0.26% 97
2018
Q1
$879K Sell
5,224
-1,547
-23% -$259K 0.26% 94
2017
Q4
$1.11M Buy
6,771
+220
+3% +$39.5K 0.33% 80
2017
Q3
$1.34M Buy
6,551
+1,459
+29% +$339K 0.33% 84
2017
Q2
$1.24M Sell
5,092
-276
-5% -$64.9K 0.32% 83
2017
Q1
$1.28M Buy
5,368
+1,200
+29% +$279K 0.36% 75
2016
Q4
$875K Sell
4,168
-2,174
-34% -$450K 0.27% 104
2016
Q3
$1.46M Buy
6,342
+730
+13% +$178K 0.42% 57
2016
Q2
$1.3K Buy
5,612
+3,547
+172% +$818K 0.14% 59
2016
Q1
$553K Buy
2,065
+677
+49% +$194K 0.21% 128
2015
Q4
$434K Buy
1,388
+203
+17% +$60.4K 0.16% 151
2015
Q3
$322K Sell
1,185
-280
-19% -$86K 0.13% 170
2015
Q2
$445 Buy
1,465
+54
+4% +$16.1K 0.12% 156
2015
Q1
$420K Buy
+1,411
New +$402K 0.16% 156

Other funds holding AGN

First Heartland Consultants's AGN Position: Q4 2018 in Review

First Heartland Consultants sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 3,419 shares — an estimated $651K sold.

First Heartland Consultants first reported a position in AGN in Q1 2015 and held it in 15 quarters. The position peaked at $1.46M in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • First Heartland Consultants reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • First Heartland Consultants sold 3,419 Allergan plc shares in Q4 2018, an estimated $651K.
  • First Heartland Consultants first reported a position in Allergan plc in Q1 2015 and held it in 15 quarters.
  • First Heartland Consultants's Allergan plc position peaked at $1.46M in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on First Heartland Consultants's 13F filing for Q4 2018, filed 12 Feb 2019.